Fundz

Evox Therapeutics Appoints Dr. Per Lundin as Chief Executive Officer

PRIVATEApr 29, 2024

Position

Chief Executive Officer

Company

Evox Therapeutics Ltd

Per Lundin
per.lundin@evoxtherapeutics.com
OxfordBiotechnologyHealth CareTherapeutics

Description

Evox Therapeutics has appointed Dr Per Lundin, Co-Founder and Chief Business Officer, as the new Chief Executive Officer (CEO) of the Company. Dr Antonin de Fougerolles has decided to step down as CEO and Director of Evox, and will continue to support the Company as a strategic adviser.

Quick answer

Evox Therapeutics Appoints Dr. Per Lundin as Chief Executive Officer (April 29, 2024). Evox Therapeutics Ltd is based in Oxford, England, United Kingdom.

Who is the new Chief Executive Officer at Evox Therapeutics Ltd?
Evox Therapeutics Ltd named Per Lundin Chief Executive Officer, announced April 29, 2024.
What did Evox Therapeutics Ltd announce on April 29, 2024?
Evox Therapeutics has appointed Dr Per Lundin, Co-Founder and Chief Business Officer, as the new Chief Executive Officer (CEO) of the Company. Dr Antonin de Fougerolles has decided to step down as CEO and Director of Evox, and will continue to support the Company as a strategic adviser.
What does Evox Therapeutics Ltd do?
Evox Therapeutics is a privately held, Oxford-based biotechnology company that is a leader in harnessing and engineering the natural delivery capabilities of exosomes to create and enable the next generation of genetic...
Where is Evox Therapeutics Ltd based?
Evox Therapeutics Ltd is based in Oxford, England, United Kingdom.
Which similar companies made leadership changes around the same time?
CureVac (April 29, 2024), Stoke Therapeutics, Inc. (April 29, 2024), Insitro (April 30, 2024) and Akero Therapeutics (April 30, 2024) also announced leadership changes within 45 days of Evox Therapeutics Ltd.

Source: Fundz verified event record.

Other recent leadership changes in Therapeutics and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at Evox Therapeutics Ltd, and when

A new leader at Evox Therapeutics Ltd brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Evox Therapeutics Ltd raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Evox Therapeutics Ltd, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Evox Therapeutics Ltd. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Evox Therapeutics Ltd

Location

Oxford, England, United Kingdom

About

Evox Therapeutics is a privately held, Oxford-based biotechnology company that is a leader in harnessing and engineering the natural delivery capabilities of exosomes to create and enable the next generation of genetic medicines. Evox uses its DeliverEX® platform to engineer exosomes to facilitate safe and precise drug delivery to hard-to-reach organs and tissues.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Evox Therapeutics Ltd changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Per
Likely contact at this company
••••••••@••••••••

See Per's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Evox Therapeutics Ltd's next move

Learn about Strategic plan

Evox Therapeutics Ltd changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.